31 related articles for article (PubMed ID: 16202931)
1. Expression of cathepsins B and D by cancer stem cells in head and neck metastatic malignant melanoma.
Sangster AB; Chang-McDonald B; Patel J; Bockett N; Paterson E; Davis PF; Tan ST
Melanoma Res; 2021 Oct; 31(5):426-438. PubMed ID: 34116545
[TBL] [Abstract][Full Text] [Related]
2. PDMS-PMOXA-Nanoparticles Featuring a Cathepsin B-Triggered Release Mechanism.
Ehrsam D; Porta F; Hussner J; Seibert I; Meyer Zu Schwabedissen HE
Materials (Basel); 2019 Sep; 12(17):. PubMed ID: 31484396
[TBL] [Abstract][Full Text] [Related]
3. Lessons learned from imaging mouse ovarian tumors: the route of probe injection makes a difference.
Han MS; Tung CH
Quant Imaging Med Surg; 2014 Jun; 4(3):156-62. PubMed ID: 24914416
[TBL] [Abstract][Full Text] [Related]
4. Combined in vivo molecular and anatomic imaging for detection of ovarian carcinoma-associated protease activity and integrin expression in mice.
Hensley HH; Roder NA; O'Brien SW; Bickel LE; Xiao F; Litwin S; Connolly DC
Neoplasia; 2012 Jun; 14(6):451-62. PubMed ID: 22787427
[TBL] [Abstract][Full Text] [Related]
5. Multi-conformation 3D QSAR study of benzenesulfonyl-pyrazol-ester compounds and their analogs as cathepsin B inhibitors.
Zhou Z; Wang Y; Bryant SH
J Mol Graph Model; 2011 Sep; 30():135-47. PubMed ID: 21798778
[TBL] [Abstract][Full Text] [Related]
6. QSAR models for predicting cathepsin B inhibition by small molecules--continuous and binary QSAR models to classify cathepsin B inhibition activities of small molecules.
Zhou Z; Wang Y; Bryant SH
J Mol Graph Model; 2010 Jun; 28(8):714-27. PubMed ID: 20194042
[TBL] [Abstract][Full Text] [Related]
7. Computational analysis of the cathepsin B inhibitors activities through LR-MMPBSA binding affinity calculation based on docked complex.
Zhou Z; Wang Y; Bryant SH
J Comput Chem; 2009 Nov; 30(14):2165-75. PubMed ID: 19242965
[TBL] [Abstract][Full Text] [Related]
8. [Significance of cathepsin B and D in physiologic and pathologic processes].
Olszewska D; Drewa T; Makarewicz R; Drewa J; Woźniak A; Maciak R
Pol Merkur Lekarski; 2001 Jan; 10(55):65-70. PubMed ID: 11320558
[TBL] [Abstract][Full Text] [Related]
9. The dilemma: does tissue expression of cathepsin D reflect tumor malignancy? The question: does the assay truly mirror cathepsin D mis-function in the tumor?
Nicotra G; Castino R; Follo C; Peracchio C; Valente G; Isidoro C
Cancer Biomark; 2010; 7(1):47-64. PubMed ID: 21045264
[TBL] [Abstract][Full Text] [Related]
10. Cathepsins B and D activity and activity ratios in normal ovaries, benign ovarian neoplasms, and epithelial ovarian cancer.
Downs LS; Lima PH; Bliss RL; Blomquist CH
J Soc Gynecol Investig; 2005 Oct; 12(7):539-44. PubMed ID: 16202931
[TBL] [Abstract][Full Text] [Related]
11. Endometrial carcinoma expresses an increased cathepsin B/D ratio.
Bradley WH; Lima PH; Rodgers L; Blomquist CH; Downs LS
Gynecol Oncol; 2008 Jan; 108(1):84-9. PubMed ID: 17980407
[TBL] [Abstract][Full Text] [Related]
12. [Proteolytic lysosomal enzymes in ovarian cancer].
Kozyreva EA; Zhordaniia KI; Bassalyk LS; Vasil'ev AV
Vopr Med Khim; 1991; 37(4):20-3. PubMed ID: 1750203
[TBL] [Abstract][Full Text] [Related]
13. [Cathepsin D activity in human ovarian carcinoma].
Reich W; Wagner F; Hofmann KD; Marzotko F; Schmeisser G
Zentralbl Gynakol; 1984; 106(3):196-200. PubMed ID: 6702349
[TBL] [Abstract][Full Text] [Related]
14. The role of cathepsin B and cystatin C in the mechanisms of invasion by ovarian cancer.
Nishikawa H; Ozaki Y; Nakanishi T; Blomgren K; Tada T; Arakawa A; Suzumori K
Gynecol Oncol; 2004 Mar; 92(3):881-6. PubMed ID: 14984956
[TBL] [Abstract][Full Text] [Related]
15. Activity of cathepsin B and D in colorectal cancer: relationships with tumour budding.
Guzińska-Ustymowicz K; Zalewski B; Kasacka I; Piotrowski Z; Skrzydlewska E
Anticancer Res; 2004; 24(5A):2847-51. PubMed ID: 15517887
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
